Alimera Sciences Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Alimera Sciences are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Alimera Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Alimera Sciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 5.3 M |
Alimera |
Alimera Sciences Relative Risk vs. Return Landscape
If you would invest (100.00) in Alimera Sciences on December 22, 2024 and sell it today you would earn a total of 100.00 from holding Alimera Sciences or generate -100.0% return on investment over 90 days. Alimera Sciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Alimera, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Alimera Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alimera Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alimera Sciences, and traders can use it to determine the average amount a Alimera Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ALIM |
Based on monthly moving average Alimera Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alimera Sciences by adding Alimera Sciences to a well-diversified portfolio.
Alimera Sciences Fundamentals Growth
Alimera Stock prices reflect investors' perceptions of the future prospects and financial health of Alimera Sciences, and Alimera Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alimera Stock performance.
| Return On Equity | -0.35 | |||
| Return On Asset | 0.0098 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 360.44 M | |||
| Shares Outstanding | 54.38 M | |||
| Price To Earning | 1.65 X | |||
| Price To Book | 7.77 X | |||
| Price To Sales | 3.02 X | |||
| Revenue | 80.75 M | |||
| EBITDA | 7.28 M | |||
| Cash And Equivalents | 7.86 M | |||
| Cash Per Share | 1.12 X | |||
| Total Debt | 67.4 M | |||
| Book Value Per Share | 0.74 X | |||
| Cash Flow From Operations | (14.26 M) | |||
| Earnings Per Share | 1.05 X | |||
| Total Asset | 153.52 M | |||
| Retained Earnings | (418.49 M) | |||
| Current Asset | 51.6 M | |||
| Current Liabilities | 7.85 M | |||
Things to note about Alimera Sciences performance evaluation
Checking the ongoing alerts about Alimera Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alimera Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alimera Sciences is not yet fully synchronised with the market data | |
| Alimera Sciences has some characteristics of a very speculative penny stock | |
| Alimera Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 80.75 M. Net Loss for the year was (20.13 M) with profit before overhead, payroll, taxes, and interest of 52 M. | |
| Alimera Sciences currently holds about 7.86 M in cash with (14.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12. | |
| Over 87.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Alimera Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alimera Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Alimera Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alimera Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alimera Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alimera Sciences' stock. These opinions can provide insight into Alimera Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |